Mallmann, M. R. and Mallmann, P. (2017). Systemic therapy for endometrial cancer. Onkologe, 23 (1). S. 34 - 37. NEW YORK: SPRINGER. ISSN 1433-0415
Full text not available from this repository.Abstract
The decision on adjuvant systemic therapy for endometrial cancer is based on the clinicopathological risk factors. A selective literature review and analysis of the current guideline recommendations were carried out. In the low-risk situation no adjuvant treatment is necessary after surgery but in medium risk patients adjuvant radiotherapy is indicated after surgery. In the high-risk situation, such as advanced carcinoma systemic chemotherapy with carboplatin-paclitaxel should be carried out. In palliative care situations a gestagen-based therapy should be considered. Due to frequent comorbidities, the risks and benefits should be carefully considered in each individual case.
Item Type: | Journal Article | ||||||||||||
Creators: |
|
||||||||||||
URN: | urn:nbn:de:hbz:38-247901 | ||||||||||||
DOI: | 10.1007/s00761-016-0129-y | ||||||||||||
Journal or Publication Title: | Onkologe | ||||||||||||
Volume: | 23 | ||||||||||||
Number: | 1 | ||||||||||||
Page Range: | S. 34 - 37 | ||||||||||||
Date: | 2017 | ||||||||||||
Publisher: | SPRINGER | ||||||||||||
Place of Publication: | NEW YORK | ||||||||||||
ISSN: | 1433-0415 | ||||||||||||
Language: | German | ||||||||||||
Faculty: | Unspecified | ||||||||||||
Divisions: | Unspecified | ||||||||||||
Subjects: | no entry | ||||||||||||
Uncontrolled Keywords: |
|
||||||||||||
Refereed: | Yes | ||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/24790 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
View Item |